TY  - GEN
AU  - Campbell,R Keith
AU  - Cobble,Michael E
AU  - Reid,Timothy S
AU  - Shomali,Mansur E
TI  - Distinguishing among incretin-based therapies. Safety, tolerability, and nonglycemic effects of incretin-based therapies
SN  - 1533-7294
PY  - 2010///1207
KW  - Adamantane
KW  - analogs & derivatives
KW  - Aged
KW  - Blood Glucose
KW  - drug effects
KW  - Diabetes Mellitus, Type 2
KW  - drug therapy
KW  - Dipeptides
KW  - therapeutic use
KW  - Dipeptidyl-Peptidase IV Inhibitors
KW  - adverse effects
KW  - Exenatide
KW  - Female
KW  - Glucagon
KW  - metabolism
KW  - Glucagon-Like Peptide 1
KW  - agonists
KW  - Glucagon-Like Peptide-1 Receptor
KW  - Glycated Hemoglobin
KW  - Humans
KW  - Hypoglycemia
KW  - Hypoglycemic Agents
KW  - Incretins
KW  - Insulin
KW  - Liraglutide
KW  - Male
KW  - Metformin
KW  - Middle Aged
KW  - Peptides
KW  - Pyrazines
KW  - Receptors, Glucagon
KW  - Risk
KW  - Sitagliptin Phosphate
KW  - Triazoles
KW  - Venoms
KW  - Weight Loss
N1  - Publication Type: Case Reports; Journal Article
ER  -